Islet of Langerhans' cell transplantation is a promising strategy for the treatment of type-1 diabetes mellitus. Results of this procedure have yet to match those of whole organ pancreas transplantation, but are rapidly improving, as witnessed by increasing rates of insulin independence and graft function (i.e., C-peptide production) after islet transplantation
Type 1 diabetes currently affects 15,000 patients in Switzerland with a rising incidence worldwide. ...
The main goal of treatment for type 1 diabetes is to control glycaemia with insulin therapy to reduc...
Anthony Bruni, Boris Gala-Lopez, Andrew R Pepper, Nasser S Abualhassan, AM James Shapiro Clinical Is...
Islet cell transplantation recently has emerged as one the most promising therapeutic approaches to ...
Beta-cell replacement either by pancreatic organ or islet cell transplantation is the only treatment...
Shapiro and colleagues recently reported a 100% cure rate for type 1 diabetes with their “Edmonton p...
Type 1 diabetes is a disease resulting from autoimmune destruction of the insulin-producing beta cel...
The clinical results recently reported by the Edmonton group in recipients of allogeneic islet graft...
Steady improvements in islet cell processing technology and immunosuppressive protocols have made pa...
Diabetes mellitus is a metabolic disease possible to treat via several different therapeutic approac...
Islet transplantation is a promising therapy for treat-ment of type 1 diabetes. A real breakthrough ...
For many years, different studies have been performed for potential methods in order to reach indepe...
Clinical islet transplantation is a -cell replacement strategy that represents a possible definitive...
The enthusiasm regarding clinical islet transplantation has been dampened by the long-term results. ...
Successful pancreas or islet transplantation is currently the only cure for type 1 diabetes mellitus...
Type 1 diabetes currently affects 15,000 patients in Switzerland with a rising incidence worldwide. ...
The main goal of treatment for type 1 diabetes is to control glycaemia with insulin therapy to reduc...
Anthony Bruni, Boris Gala-Lopez, Andrew R Pepper, Nasser S Abualhassan, AM James Shapiro Clinical Is...
Islet cell transplantation recently has emerged as one the most promising therapeutic approaches to ...
Beta-cell replacement either by pancreatic organ or islet cell transplantation is the only treatment...
Shapiro and colleagues recently reported a 100% cure rate for type 1 diabetes with their “Edmonton p...
Type 1 diabetes is a disease resulting from autoimmune destruction of the insulin-producing beta cel...
The clinical results recently reported by the Edmonton group in recipients of allogeneic islet graft...
Steady improvements in islet cell processing technology and immunosuppressive protocols have made pa...
Diabetes mellitus is a metabolic disease possible to treat via several different therapeutic approac...
Islet transplantation is a promising therapy for treat-ment of type 1 diabetes. A real breakthrough ...
For many years, different studies have been performed for potential methods in order to reach indepe...
Clinical islet transplantation is a -cell replacement strategy that represents a possible definitive...
The enthusiasm regarding clinical islet transplantation has been dampened by the long-term results. ...
Successful pancreas or islet transplantation is currently the only cure for type 1 diabetes mellitus...
Type 1 diabetes currently affects 15,000 patients in Switzerland with a rising incidence worldwide. ...
The main goal of treatment for type 1 diabetes is to control glycaemia with insulin therapy to reduc...
Anthony Bruni, Boris Gala-Lopez, Andrew R Pepper, Nasser S Abualhassan, AM James Shapiro Clinical Is...
DOI
Add to ORKG